125 related articles for article (PubMed ID: 36972392)
1. Hepatic C-X-C chemokine receptor type 6-expressing innate lymphocytes limit detrimental myeloid hyperactivation in acute liver injury.
Heymann F; Mossanen JC; Peiseler M; Niemietz PM; Araujo David B; Krenkel O; Liepelt A; Batista Carneiro M; Kohlhepp MS; Kubes P; Tacke F
Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972392
[TBL] [Abstract][Full Text] [Related]
2. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
[TBL] [Abstract][Full Text] [Related]
3. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
4. Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury.
Mossanen JC; Krenkel O; Ergen C; Govaere O; Liepelt A; Puengel T; Heymann F; Kalthoff S; Lefebvre E; Eulberg D; Luedde T; Marx G; Strassburg CP; Roskams T; Trautwein C; Tacke F
Hepatology; 2016 Nov; 64(5):1667-1682. PubMed ID: 27302828
[TBL] [Abstract][Full Text] [Related]
5. Role of caspase-1 and interleukin-1beta in acetaminophen-induced hepatic inflammation and liver injury.
Williams CD; Farhood A; Jaeschke H
Toxicol Appl Pharmacol; 2010 Sep; 247(3):169-78. PubMed ID: 20637792
[TBL] [Abstract][Full Text] [Related]
6. Long term intravital multiphoton microscopy imaging of immune cells in healthy and diseased liver using CXCR6.Gfp reporter mice.
Heymann F; Niemietz PM; Peusquens J; Ergen C; Kohlhepp M; Mossanen JC; Schneider C; Vogt M; Tolba RH; Trautwein C; Martin C; Tacke F
J Vis Exp; 2015 Mar; (97):. PubMed ID: 25866988
[TBL] [Abstract][Full Text] [Related]
7. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity.
Liu ZX; Govindarajan S; Kaplowitz N
Gastroenterology; 2004 Dec; 127(6):1760-74. PubMed ID: 15578514
[TBL] [Abstract][Full Text] [Related]
8. Functional role of endothelial CXCL16/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders.
Collado A; Marques P; Escudero P; Rius C; Domingo E; Martinez-Hervás S; Real JT; Ascaso JF; Piqueras L; Sanz MJ
Cardiovasc Res; 2018 Nov; 114(13):1764-1775. PubMed ID: 29800106
[TBL] [Abstract][Full Text] [Related]
9. The regulation of T-cell recruitment to the human liver during acute liver failure.
Tuncer C; Oo YH; Murphy N; Adams DH; Lalor PF
Liver Int; 2013 Jul; 33(6):852-63. PubMed ID: 23617240
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 disrupts liver repair in acetaminophen-induced acute liver failure.
Roth K; Strickland J; Pant A; Freeborn R; Kennedy R; Rockwell CE; Luyendyk JP; Copple BL
Front Immunol; 2023; 14():1303921. PubMed ID: 38094302
[TBL] [Abstract][Full Text] [Related]
11. Cathelicidin promotes liver repair after acetaminophen-induced liver injury in mice.
Zhai T; Zhang J; Zhang J; Liu B; Zhou Z; Liu F; Wu Y
JHEP Rep; 2023 Apr; 5(4):100687. PubMed ID: 36923240
[TBL] [Abstract][Full Text] [Related]
12. IL-17 deficiency attenuates acetaminophen-induced hepatotoxicity in mice.
Lee HC; Liao CC; Day YJ; Liou JT; Li AH; Liu FC
Toxicol Lett; 2018 Aug; 292():20-30. PubMed ID: 29689376
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil depletion protects against murine acetaminophen hepatotoxicity.
Liu ZX; Han D; Gunawan B; Kaplowitz N
Hepatology; 2006 Jun; 43(6):1220-30. PubMed ID: 16729305
[TBL] [Abstract][Full Text] [Related]
14. Antigens of
Choreño-Parra JA; Jiménez-Álvarez LA; Muñoz-Torrico M; Ramírez-Martínez G; Jiménez-Zamudio LA; Salinas-Lara C; García-Latorre EA; Zúñiga J
Front Immunol; 2020; 11():582414. PubMed ID: 33117393
[TBL] [Abstract][Full Text] [Related]
15. High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of γδ T cells with macrophages.
Wang X; Sun R; Wei H; Tian Z
Hepatology; 2013 Jan; 57(1):373-84. PubMed ID: 22821628
[TBL] [Abstract][Full Text] [Related]
16. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
Zhu H; Zhang Q; Chen G
Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
[TBL] [Abstract][Full Text] [Related]
17. MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure.
Triantafyllou E; Pop OT; Possamai LA; Wilhelm A; Liaskou E; Singanayagam A; Bernsmeier C; Khamri W; Petts G; Dargue R; Davies SP; Tickle J; Yuksel M; Patel VC; Abeles RD; Stamataki Z; Curbishley SM; Ma Y; Wilson ID; Coen M; Woollard KJ; Quaglia A; Wendon J; Thursz MR; Adams DH; Weston CJ; Antoniades CG
Gut; 2018 Feb; 67(2):333-347. PubMed ID: 28450389
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-Inducible Factor-2α Reprograms Liver Macrophages to Protect Against Acute Liver Injury Through the Production of Interleukin-6.
Gao RY; Wang M; Liu Q; Feng D; Wen Y; Xia Y; Colgan SP; Eltzschig HK; Ju C
Hepatology; 2020 Jun; 71(6):2105-2117. PubMed ID: 31529728
[TBL] [Abstract][Full Text] [Related]
19. C-C chemokine receptor type 7 (CCR7) regulates hepatic CD8 + T cell homeostasis and response to acute liver injury.
Niemietz P; Peiseler M; Kohlhepp M; Horn P; Matchett K; Wang Y; Haas L; Zhang T; Bruneau A; Guillot A; Berger H; Liepelt A; Warzecha K; Demske C; Möckel D; Lammers T; Henderson N; Heymann F; Tacke F
Hepatology; 2024 Jan; ():. PubMed ID: 38231043
[TBL] [Abstract][Full Text] [Related]
20. IL-33 signalling in liver immune cells enhances drug-induced liver injury and inflammation.
Antunes MM; Araújo AM; Diniz AB; Pereira RVS; Alvarenga DM; David BA; Rocha RM; Lopes MAF; Marchesi SC; Nakagaki BN; Carvalho É; Marques PE; Ryffel B; Quesniaux V; Guabiraba Brito R; Filho JCA; Cara DC; Rezende RM; Menezes GB
Inflamm Res; 2018 Jan; 67(1):77-88. PubMed ID: 29032512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
